MPS Powered by Eureka

Submission Tilte

Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)

Submission Abstract:

The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which play pivotal roles in the pathogenesis and progression of CKD. Furthermore, it will encompass an in-depth examination of innovative treatment modalities, including gene therapy, immunotherapy, and precision medicine, elucidating their potential applications and efficacy in CKD management. Additionally, the issue will emphasize the importance of identifying and validating novel biomarkers for early detection, prognosis, and therapeutic monitoring of CKD progression, addressing the urgent need for reliable indicators to guide clinical decision-making and improve patient outcomes. By encompassing a diverse range of research articles, reviews, and perspectives from leading experts in the field, this thematic issue seeks to advance our understanding of CKD pathophysiology and foster the development of transformative therapies and diagnostic tools to combat this debilitating condition.